Guard Therapeutics International AB Share Price
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.4 SEK | -4.70% | -1.39% | -20.67% |
Sales 2023 | - | Sales 2024 * | - | Capitalization | 300M 3.27B 25.01B |
---|---|---|---|---|---|
Net income 2023 | -113M -1.23B -9.43B | Net income 2024 * | -99M -1.08B -8.26B | EV / Sales 2023 | - |
Net cash position 2023 * | 67M 731M 5.59B | Net cash position 2024 * | 70M 764M 5.84B | EV / Sales 2024 * | - |
P/E ratio 2023 |
-3.18
x | P/E ratio 2024 * |
-3.03
x | Employees | 12 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 60.37% |
1 day | -4.70% | ||
1 week | -1.39% | ||
Current month | +53.51% | ||
1 month | +62.29% | ||
3 months | +15.45% | ||
6 months | -12.07% | ||
Current year | -20.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01/18/01 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 14/20/14 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 01/21/01 |
Göran Forsberg
BRD | Director/Board Member | 61 | 29/19/29 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 01/22/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 28.4 | -4.70% | 1 023 |
26/24/26 | 29.8 | 0.00% | 9,584 |
25/24/25 | 29.8 | -2.61% | 7,991 |
24/24/24 | 30.6 | +3.38% | 3,887 |
23/24/23 | 29.6 | +2.78% | 9,270 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 04:29 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.67% | 27.35M | |
+1.51% | 42.75B | |
+48.37% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GUARD Stock